株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生細胞イメージング (ライブセルイメージング) の世界市場 (〜2023年):機器・消耗品・ソフトウェア・サービス

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023

発行 MarketsandMarkets 商品コード 330389
出版日 ページ情報 英文 159 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.74円で換算しております。
Back to Top
生細胞イメージング (ライブセルイメージング) の世界市場 (〜2023年):機器・消耗品・ソフトウェア・サービス Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023
出版日: 2019年02月12日 ページ情報: 英文 159 Pages
概要

生細胞イメージング (ライブセルイメージング) の市場は予測期間中8.9%のCAGR (年間複合成長率) で推移し、2018年の19億米ドルから、2023年には29億米ドルの規模に成長すると予測されています。創薬におけるハイコンテントスクリーニング (HCS) 技術の導入拡大、癌罹患率の上昇、研究資金の拡大などの要因が同市場の成長を推進しています。しかし一方で、HCSシステムの高コスト性、技術を有する人材の不足などの要因が同市場のさらなる成長の障壁となっています。

当レポートでは、世界の生細胞イメージング (ライブセルイメージング) の市場を調査し、市場および技術の概要、市場成長への各種影響因子および市場機会の分析、製品・サービス・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 課題

第6章 生細胞イメージング市場の分析・予測:製品・サービス別

  • イントロダクション
  • 機器
    • 顕微鏡
    • スタンドアロン型システム
    • セルアナライザー
    • 付属品
  • 消耗品
    • 試薬
    • アッセイキット
    • 培地
    • その他
  • ソフトウェア
  • サービス

第7章 生細胞イメージング市場の分析・予測:用途別

  • イントロダクション
  • 細胞生物学
  • 幹細胞
  • 発生生物学
  • 創薬

第8章 生細胞イメージング市場の分析・予測:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 学術・研究機関
  • CRO

第9章 生細胞イメージング市場の分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域

第10章 競合環境

  • イントロダクション
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 競合シナリオ

第11章 企業プロファイル

  • DANAHER CORPORATION
  • CARL ZEISS AG
  • ニコン
  • オリンパス
  • PERKINELMER
  • GE HEALTHCARE
  • BRUKER
  • THERMO FISHER SCIENTIFIC
  • SARTORIUS AG
  • BIOTEK INSTRUMENTS
  • ETALUMA
  • CYTOSMART TECHNOLOGIES
  • NANOENTEK

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 2: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 3: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 4: LIVE CELL IMAGING MICROSCOPES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 5: LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: LIVE CELL IMAGING CELL ANALYZERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 7: LIVE CELL IMAGING ACCESSORIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 9: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: LIVE CELL IMAGING REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: LIVE CELL IMAGING ASSAY KITS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: LIVE CELL IMAGING MEDIA MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 13: LIVE CELL IMAGING OTHER CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 15: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 17: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: LIVE CELL IMAGING MARKET FOR STEM CELLS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 22: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 24: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: LIVE CELL IMAGING MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 30: NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 31: US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 32: US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 33: US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 34: US: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 35: CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 36: CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 38: CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 39: EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 41: EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 43: EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 44: GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 45: GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 46: GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 47: GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 48: UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 49: UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 51: UK: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 52: FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 53: FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 54: FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 55: FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 56: ROE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 57: ROE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: ROE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 59: ROE: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 65: CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 66: CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 68: CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 70: JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 72: JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 73: INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 74: INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 76: INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 77: ROAPAC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 78: ROAPAC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 79: ROAPAC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 80: ROAPAC: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: ROW: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 82: ROW: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: ROW: LIVE CELL IMAGING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 84: ROW: LIVE CELL IMAGING MARKET, BY END USER, 2016-2023 (USD MILLION) 112  
  • TABLE 85: PRODUCT LAUNCHES AND ENHANCEMENTS, 2015-2018
  • TABLE 86: AGREEMENTS, CONTRACTS, COLLABORATIONS, AND PARTNERSHIPS, 2015-2018
  • TABLE 87: ACQUISITIONS, 2015-2018
  • TABLE 88: EXPANSIONS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: LIVE CELL IMAGING MARKET SEGMENTATION
  • FIGURE 2: LIVE CELL IMAGING MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT AND SERVICE (2018)
  • FIGURE 9: MICROSCOPES SEGMENT HELD THE LARGEST SHARE OF THE LIVE CELL IMAGING INSTRUMENTS MARKET IN 2018
  • FIGURE 10: LIVE CELL IMAGING CONSUMABLES MARKET SHARE, BY TYPE (2018)
  • FIGURE 11: CELL BIOLOGY APPLICATIONS TO DOMINATE THE LIVE CELL IMAGING MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT HELD THE LARGEST SHARE OF THE LIVE CELL IMAGING MARKET IN 2018
  • FIGURE 13: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 14: GROWING ADOPTION OF HCS TECHNIQUES AND RISING INCIDENCE OF CANCER ARE KEY FACTORS DRIVING MARKET GROWTH
  • FIGURE 15: INSTRUMENTS DOMINATED THE NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2018
  • FIGURE 16: CELL BIOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN LIVE CELL IMAGING MARKET IN 2018
  • FIGURE 17: CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 18: LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: INSTRUMENTS SEGMENT TO DOMINATE THE LIVE CELL IMAGING MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: CELL BIOLOGY APPLICATIONS TO DOMINATE THE LIVE CELL IMAGING MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: LIVE CELL IMAGING MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 22: LIVE CELL IMAGING MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 23: NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
  • FIGURE 24: EUROPE: LIVE CELL IMAGING MARKET SNAPSHOT
  • FIGURE 25: ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT
  • FIGURE 26: ROW: LIVE CELL IMAGING MARKET SNAPSHOT
  • FIGURE 27: KEY DEVELOPMENTS IN THE LIVE CELL IMAGING MARKET BETWEEN 2015 AND 2018
  • FIGURE 28: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 29: LIVE CELL IMAGING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING (2017)
  • FIGURE 30: DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 31: CARL ZEISS AG: COMPANY SNAPSHOT (2017)
  • FIGURE 32: NIKON CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 33: OLYMPUS CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 34: PERKINELMER: COMPANY SNAPSHOT (2017)
  • FIGURE 35: GE HEALTHCARE: COMPANY SNAPSHOT (2017)
  • FIGURE 36: BRUKER: COMPANY SNAPSHOT (2017)
  • FIGURE 37: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 38: SARTORIUS: COMPANY SNAPSHOT (2017)
目次
Product Code: BT 3390

"The live cell imaging market is projected to grow at a CAGR of 8.9% during the forecast period."

The live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% during the forecast period. Market growth is largely driven by the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research. However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.

By product & service, the consumables segment is expected to grow at the highest rate during the forecast period.

On the basis of product and service, the global live cell imaging market is segmented into instruments, consumables, software, and services. The consumables segment is expected to grow at the highest CAGR during the forecast period. Unlike instruments, which are considered as a one-time investment, consumables are required to be purchased frequently. This is the major factor driving the growth of the live cell imaging consumables market. The increasing applications of live cell imaging assays and advancements in live cell imaging technologies are some of the other major factors that are driving the demand for live cell imaging consumables.

The pharmaceutical & biotechnology companies segment dominated the market in 2018.

On the basis of end user, the live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). In 2018, the pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market. The large share of this segment can be attributed to the increasing R&D activities and the patent cliff of various blockbuster drugs.

The Asia Pacific live cell imaging market is expected to grow at the highest CAGR during the forecast period.

Asia Pacific, comprising China, India, Japan, and Rest of Asia Pacific countries offers high-growth opportunities for players in the live cell imaging market. This segment is slated to register the highest CAGR during the forecast period. Some of the factors driving market growth in the Asia Pacific region are government initiatives for research on stem cell therapy, increasing aging population, rising prominence for regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 2-25% and Tier 3-20%
  • By Designation - C-level-43%, Director Level-32%, Others-25%
  • By Region - North America-38%, Europe-29%, Asia Pacific-23%, RoW-10%

The key players in the live cell imaging market are: Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).

Research Coverage:

The report analyzes the live cell imaging market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product & service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the products and services offered by the top players in the live cell imaging market. The report analyzes the market based on product & service, application, end user, and region
  • Product Development/Innovation: Detailed insights on new product launches in the live cell imaging market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various live cell imaging products and services across regions
  • Market Diversification: Exhaustive information about products and services, untapped regions, recent developments, and investments in the live cell imaging market
  • Competitive Assessment: In-depth assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key date from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LIVE CELL IMAGING: MARKET OVERVIEW
  • 4.2. LIVE CELL IMAGING MARKET, BY PRODUCT AND SERVICE, 2018
  • 4.3. LIVE CELL IMAGING MARKET, BY APPLICATION, 2018
  • 4.4. LIVE CELL IMAGING MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising adoption of high-content screening techniques in drug discovery
      • 5.2.1.2. Rising incidence of cancer
      • 5.2.1.3. Growing availability of funds for research
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of high-content screening systems
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Application of HCS in personalized medicine
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Maintaining cell viability & cellular environment in the culture
      • 5.2.4.2. Dearth of skilled professionals

6. LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. INSTRUMENTS
    • 6.2.1. INCREASING DEMAND FOR LIVE CELLS FOR ANALYSIS IN THE BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES TO DRIVE THE ADOPTION OF LIVE CELL IMAGING INSTRUMENTS
    • 6.2.2. MICROSCOPES
    • 6.2.3. STANDALONE SYSTEMS
    • 6.2.4. CELL ANALYZERS
    • 6.2.5. ACCESSORIES
  • 6.3. CONSUMABLES
    • 6.3.1. REAGENTS
      • 6.3.1.1. Reagents segment to account for the largest share of the live cell imaging consumables market in 2018
    • 6.3.2. ASSAY KITS
      • 6.3.2.1. Repeat purchase of assay kits - key driver for market growth
    • 6.3.3. MEDIA
      • 6.3.3.1. Development of new and advanced technologies has resulted in an increased demand for high-quality media in biomedical research and processing
    • 6.3.4. OTHER CONSUMABLES
  • 6.4. SOFTWARE
    • 6.4.1. TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION - A KEY DRIVER FOR MARKET GROWTH
  • 6.5. SERVICES
    • 6.5.1. AVAILABILITY OF A WIDE RANGE OF SERVICES AND GROWING NUMBER OF INITIATIVES BY KEY PLAYERS TO DRIVE THE SERVICES MARKET

7. LIVE CELL IMAGING MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CELL BIOLOGY
    • 7.2.1. INCREASING PREVALENCE OF CANCER TO DRIVE THE CELL BIOLOGY APPLICATION SEGMENT
  • 7.3. STEM CELLS
    • 7.3.1. IMPORTANCE OF STEM CELL RESEARCH HAS BOOSTED INVESTMENTS IN THIS AREA
  • 7.4. DEVELOPMENTAL BIOLOGY
    • 7.4.1. GROWING RESEARCH IN DEVELOPMENTAL BIOLOGY A KEY DRIVER OF MARKET GROWTH
  • 7.5. DRUG DISCOVERY
    • 7.5.1. USE OF HCS CELL-BASED ASSAYS HAS GROWN IN DRUG DEVELOPMENT STUDIES

8. LIVE CELL IMAGING MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1. INCREASING R&D ACTIVITIES AND THE PATENT CLIFF OF VARIOUS BLOCKBUSTER DRUGS TO INCREASE THE DEMAND FOR LIVE CELL IMAGING PRODUCTS IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.3. ACADEMIC & RESEARCH INSTITUTES
    • 8.3.1. DEMAND FOR LIVE CELL IMAGING PRODUCTS TO INCREASE IN ACADEMIC AND RESEARCH INSTITUTES OWING TO THE RISING FOCUS OF THESE END USERS ON STRENGTHENING THEIR OWN DRUG DISCOVERY RESEARCH PROGRAMS
  • 8.4. CONTRACT RESEARCH ORGANIZATIONS
    • 8.4.1. GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE THE DEMAND FOR LIVE CELL IMAGING SYSTEMS IN CONTRACT RESEARCH ORGANIZATIONS

9. LIVE CELL IMAGING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. US dominates the North American live cell imaging market primarily due to the strong trend of pharmaceutical & biotechnology research and the high burden of cancer
    • 9.2.2. CANADA
      • 9.2.2.1. Government initiatives to promote research and the need to combat cancer are the key factors driving the growth of the live cell imaging market in Canada
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Presence of a large number of academic research institutes and increasing R&D spending to drive the demand for live cell imaging in Germany
    • 9.3.2. UK
      • 9.3.2.1. UK has seen a surge in the prevalence of cancer; by 2030, an estimated 4 million people are expected to be diagnosed with the disease
    • 9.3.3. FRANCE
      • 9.3.3.1. Growth in the French live cell imaging market is attributed to the large pharmaceutical manufacturing industry and the high public expenditure on R&D in France
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
      • 9.4.1.1. China to register the highest growth rate in the Asia Pacific live cell imaging market during the forecast period
    • 9.4.2. JAPAN
      • 9.4.2.1. Increasing aging population, rising prominence for regenerative medicine research, and increasing number of researchers to support market growth in Japan
    • 9.4.3. INDIA
      • 9.4.3.1. Favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry to drive market growth
    • 9.4.4. ROAPAC
  • 9.5. ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. LIVE CELL IMAGING MARKET SHARE ANALYSIS (2017)
  • 10.3. COMPETITIVE LEADERSHIP MAPPING
    • 10.3.1. VISIONARY LEADERS
    • 10.3.2. INNOVATORS
    • 10.3.3. DYNAMIC DIFFERENTIATORS
    • 10.3.4. EMERGING COMPANIES
  • 10.4. COMPETITIVE SCENARIO

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1. DANAHER CORPORATION
  • 11.2. CARL ZEISS AG
  • 11.3. NIKON CORPORATION
  • 11.4. OLYMPUS CORPORATION
  • 11.5. PERKINELMER
  • 11.6. GE HEALTHCARE
  • 11.7. BRUKER
  • 11.8. THERMO FISHER SCIENTIFIC
  • 11.9. SARTORIUS AG
  • 11.10. BIOTEK INSTRUMENTS
  • 11.11. ETALUMA
  • 11.12. CYTOSMART TECHNOLOGIES
  • 11.13. NANOENTEK

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE: LIVE CELL IMAGING MARKET
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS
Back to Top